米索前列醇联合妥塞敏治疗产后出血中的临床效果及对产妇出血量的影响

The Clinical Effect of Misoprostol Combined with Tousaimin in the Treatment of Postpartum Hemorrhage and Its Influence on the Amount of Maternal Bleeding

目的:探讨米索前列联合妥塞敏治疗产后出血中的临床效果及对产妇出血量的影响。方法:在2018年4月~2020年4月间于某院接受治疗的产后出血产妇76例作为研究对象,使用随机数字法分为观察组与对照组各38例,对照组单独使用米索前列醇治疗,观察组则在对照组基础之上加用妥塞敏进行治疗,观察两组治疗临床效果。结果:观察组治疗总有效率高于对照组(P<0.05),观察组产后出血情况优于对照组(P<0.05)。结论:米索前列醇联合妥塞敏在治疗产后出血方面疗效显著,可明显减少患者出血量,可临床推广应用。

Objective:To investigate the clinical effect of misoprostol combined with tousaimin in the treatment of postpartum hemorrhage and its influence on the amount of maternal bleeding.Methods:From April 2018 to April 2020,76 cases of postpartum hemorrhage in a hospital were randomly divided into observation group(38 cases)and control group(38 cases).The control group was treated with misoprostol alone,while the observation group was treated with tousaimin on the basis of the control group.The clinical effect of the two groups was observed.Results:The total effective rate of the observation group was higher than that of the control group(P<0.05),and the postpartum hemorrhage of the observation group was better than that of the control group(P<0.05).Conclusion:The curative effect of misoprostol combined with tousaimin in the treatment of postpartum hemorrhage is significant,which can significantly reduce the amount of bleeding patients,and is worthy of clinical application.